Jørgen de Jonge

1.7k citations

27 papers · 757 indexed · h-index 17

Co-authors: Anke Huckriede Sietske K. Rosendahl Huber Josine van Beek Debbie van Baarle Willem Luytjes Jan Wilschut Marijke Holtrop Harry van Dijken
Topics: Influenza Virus Research Studies (14 papers)Viral gastroenteritis research and epidemiology (8 papers)Respiratory viral infections research (5 papers)
Cited by: Infectious Diseases Immunology Epidemiology
Journals: PLoS ONE Advanced Drug Delivery Reviews Journal of Virology
Partner nations: Netherlands Russia Canada

In The Last Decade

Jørgen de Jonge

26 papers receiving 729 citations

Peers

Countries citing papers authored by Jørgen de Jonge

Since Specialization

Citations

This map shows the geographic impact of Jørgen de Jonge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jørgen de Jonge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jørgen de Jonge more than expected).

Fields of papers citing papers by Jørgen de Jonge

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jørgen de Jonge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jørgen de Jonge. The network helps show where Jørgen de Jonge may publish in the future.

Co-authorship network of co-authors of Jørgen de Jonge

This figure shows the co-authorship network connecting the top 25 collaborators of Jørgen de Jonge. A scholar is included among the top collaborators of Jørgen de Jonge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jørgen de Jonge. Jørgen de Jonge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Memory-CD8+-T-Cell Response to Conserved Influenza Virus Epitopes in Mice Is Not Influenced by Time Since Previous Infection 2024 ·Vaccines ·(unknown),(unknown),(unknown),Harry van Dijken,(unknown),Martijn Vos,José A. M. Borghans,Debbie van Baarle,Jørgen de Jonge	0
2	Modified influenza M158–66 peptide vaccination induces non-relevant T-cells and may enhance pathology after challenge 2023 ·npj Vaccines ·(unknown),(unknown),Harry van Dijken,(unknown),(unknown),(unknown),Paul Roholl,José A. M. Borghans,Debbie van Baarle,Jørgen de Jonge	2
3	A universal influenza mRNA vaccine candidate boosts T cell responses and reduces zoonotic influenza virus disease in ferrets 2022 ·Science Advances ·(unknown),(unknown),Harry van Dijken,Hiromi Muramatsu,(unknown),(unknown),(unknown),Mitchell Beattie,Paulo J.C. Lin,José A. Ferreira,Judith M. A. van den Brand,Debbie van Baarle,Norbert Pardi,Jørgen de Jonge	27
4	Influenza Infection in Ferrets with SARS-CoV-2 Infection History 2022 ·Microbiology Spectrum ·(unknown),(unknown),Harry van Dijken,(unknown),(unknown),Lisa Wijsman,(unknown),(unknown),Puck B. van Kasteren,Judith M. A. van den Brand,Jørgen de Jonge	3
5	Pathology and Immunity After SARS-CoV-2 Infection in Male Ferrets Is Affected by Age and Inoculation Route 2021 ·Frontiers in Immunology ·(unknown),Harry van Dijken,Lisa Wijsman,(unknown),(unknown),Jolanda Kool,(unknown),Paul Roholl,Adam Meijer,Puck B. van Kasteren,Jørgen de Jonge	23
6	Synthetic Peptides That Antagonize the Angiotensin-Converting Enzyme-2 (ACE-2) Interaction with SARS-CoV-2 Receptor Binding Spike Protein 2021 ·Journal of Medicinal Chemistry ·Afsaneh Sadremomtaz,(unknown),Angel J. Ruiz‐Moreno,Alessandra Monti,Chao Wang,Taha Azad,John C. Bell,Nunzianna Doti,Marco A. Velasco‐Velázquez,Debora de Jong,Jørgen de Jonge,Jolanda M. Smit,Alexander Dömlingꝉ,Harry van Goor,Matthew R. Groves	27
7	Systemic and respiratory T-cells induced by seasonal H1N1 influenza protect against pandemic H2N2 in ferrets 2020 ·Communications Biology ·(unknown),(unknown),Harry van Dijken,José A. Ferreira,Jørgen de Jonge	13
8	H7N9 influenza split vaccine with SWE oil-in-water adjuvant greatly enhances cross-reactive humoral immunity and protection against severe pneumonia in ferrets 2020 ·npj Vaccines ·Jørgen de Jonge,Harry van Dijken,(unknown),Sanne Spijkers,(unknown),Rineke de Jong,Paul Roholl,(unknown),(unknown),Paulo Lee Ho,Livia Brunner,Nicolas Collin,Martin Friede,José A. Ferreira,Willem Luytjes	21
9	Whole-Inactivated Influenza Virus Is a Potent Adjuvant for Influenza Peptides Containing CD8+ T Cell Epitopes 2018 ·Frontiers in Immunology ·Peter C. Soema,Sietske K. Rosendahl Huber,(unknown),Ronald Jacobi,(unknown),Ernst C. Soethout,Wim Jiskoot,Jørgen de Jonge,(unknown),Gideon Kersten,Jean‐Pierre Amorij	11
10	H7N9 Live Attenuated Influenza Vaccine Is Highly Immunogenic, Prevents Virus Replication, and Protects Against Severe Bronchopneumonia in Ferrets 2016 ·Molecular Therapy ·Jørgen de Jonge,Irina Isakova–Sivak,Harry van Dijken,Sanne Spijkers,(unknown),Rineke de Jong,(unknown),Paul Roholl,Larisa Rudenko	28
11	Synthetic Long Peptide Influenza Vaccine Containing Conserved T and B Cell Epitopes Reduces Viral Load in Lungs of Mice and Ferrets 2015 ·PLoS ONE ·Sietske K. Rosendahl Huber,Marcel Camps,Ronald Jacobi,(unknown),Harry van Dijken,Josine van Beek,Ferry Ossendorp,Jørgen de Jonge	32
12	T Cell Responses to Viral Infections â€“ Opportunities for Peptide Vaccination 2014 ·Frontiers in Immunology ·Sietske K. Rosendahl Huber,Josine van Beek,Jørgen de Jonge,Willem Luytjes,Debbie van Baarle	158
13	Fast vaccine design and development based on correlates of protection (COPs): Influenza as a trendsetter 2014 ·Human Vaccines & Immunotherapeutics ·Cécile A. C. M. van,Siri Mjaaland,Lisbeth Meyer Næss,(unknown),Éva Gönczöl,Karen Smith Korsholm,Jon Hansen,Jørgen de Jonge,Gideon Kersten,(unknown),Amanda Semper,Corine P. Kruiswijk,Fredrik Oftung	16
14	Improvement of H5N1 influenza vaccine viruses: Influence of internal gene segments of avian and human origin on production and hemagglutinin content 2011 ·Vaccine ·(unknown),Jørgen de Jonge,Michael Laue,Thorsten Wolff	25
15	Inulin sugar glasses preserve the structural integrity and biological activity of influenza virosomes during freeze-drying and storage 2007 ·European Journal of Pharmaceutical Sciences ·Jørgen de Jonge,Jean‐Pierre Amorij,Wouter L.J. Hinrichs,Jan Wilschut,Anke Huckriede,Henderik W. Frijlink	43
16	Preservation of Influenza Virosome Structure and Function During Freeze-Drying and Storage 2007 ·Journal of Liposome Research ·Jan Wilschut,Jørgen de Jonge,Anke Huckriede,Jean‐Pierre Amorij,Wouter L.J. Hinrichs,Henderik W. Frijlink	11
17	Cellular Delivery of siRNA Mediated by Fusion-Active Virosomes 2007 ·Journal of Liposome Research ·Anke Huckriede,Jørgen de Jonge,Marijke Holtrop,Jan Wilschut	15
18	Use of a dialyzable short-chain phospholipid for efficient solubilization and reconstitution of influenza virus envelopes 2006 ·Biochimica et Biophysica Acta (BBA) - Biomembranes ·Jørgen de Jonge,Pieter Schoen,(unknown),Toon Stegmann,Jan Wilschut,Anke Huckriede	26
19	Reconstituted influenza virus envelopes as an efficient carrier system for cellular delivery of small-interfering RNAs 2005 ·Gene Therapy ·Jørgen de Jonge,Marijke Holtrop,J Wilschut,Anke Huckriede	55
20	Virosomes for antigen and DNA delivery 2004 ·Advanced Drug Delivery Reviews ·Toos Daemen,(unknown),Laura Bungener,Jørgen de Jonge,Anke Huckriede,J. Wilschut	78

About Jørgen de Jonge

Jørgen de Jonge is a scholar working on Infectious Diseases, Epidemiology and Animal Science and Zoology, having authored 27 papers that have together received 757 indexed citations. Recurring topics across this work include Influenza Virus Research Studies (14 papers), Viral gastroenteritis research and epidemiology (8 papers) and Respiratory viral infections research (5 papers). The work is most often cited by research in Infectious Diseases (229 citations), Immunology (220 citations) and Epidemiology (289 citations). Jørgen de Jonge has collaborated with scholars based in Netherlands, Russia and Canada. Frequent co-authors include Anke Huckriede, Sietske K. Rosendahl Huber, Josine van Beek, Debbie van Baarle, Willem Luytjes, Jan Wilschut, Marijke Holtrop, Harry van Dijken, J Wilschut and J. Wilschut. Their work appears in journals such as PLoS ONE, Advanced Drug Delivery Reviews and Journal of Virology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact